Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Depreciation & Amortization (CF) (2022)

CervoMed's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at -$883995.0 for Q4 2022.

  • For Q4 2022, Depreciation & Amortization (CF) changed N/A year-over-year to -$883995.0; the TTM value through Sep 2023 reached -$883995.0, down 339.61%, while the annual FY2021 figure was $93416.0, 9.45% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2022 was -$883995.0 at CervoMed, down from $368924.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at -$883995.0 in Q4 2022 and bottomed at -$883995.0 in Q4 2022.